| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ticlopidine hydrochloride 250mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Asasantin Retard m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dipyridamole+aspirin 200mg/25mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| ReoPro 10mg/5mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Abciximab 10mg/5mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Aspirin 75mg soluble tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Aspirin 300mg m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Disprin CV 300mg m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Pump-Hep 20,000units/20mL infusion |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Pump-Hep 10,000units/10mL infusion |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Multiparin 125,000iu/5mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Multiparin 25,000iu/5mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Micropirin 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Caspac XL 162.5mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Aspirin 162.5mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Enprin 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Nu-Seals Cardio 75 e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Caprin 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| postMI 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| postMI 75mg dispersible tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| postMI 300mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Aspirin 75mg e/c tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Nu-Seals Aspirin 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Aspirin 100mg m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Disprin CV 100mg m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Aspirin 75mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Angettes 75mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Aspirin 75mg dispersible tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dipyridamole 10mg/2mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dipyridamole 50mg/5mL oral suspension - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Persantin Retard 200mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dipyridamole 200mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Modaplate 25mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Modaplate 100mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cerebrovase 100mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cerebrovase 25mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Multiparin 5000iu/5mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin 25,000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin 5000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin 5000iu/5mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin 1000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin 20,000iu/20mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 125,000iu/5mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 25,000iu/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 10,000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 25,000iu/5mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 25,000iu/5mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 5000iu/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 5000iu/5mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 5000iu/5mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 1000iu/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Isotard 50XL m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Isib 50XL m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Isodur 50XL m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Isodur 25XL m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Isotard 50XL m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Isotard 25XL m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 100mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 60mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 30mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 15mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 10mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 5mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 20mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 10mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| MXL 60mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| MXL 30mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 200mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 150mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 120mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 90mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Sevredol 50mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 50mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Zomorph 60mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Zomorph 30mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 50mg/50mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Rapiject Morphine sulphate 100mg/50mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Rapiject Morphine sulphate 50mg/50mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 100mg/50mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 50mg/50mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morcap SR 50mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 75mg rectal tampon |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 50mg rectal tampon |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 35mg rectal tampon |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 20mg/mL oral solution - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Pharma-Ject Morphine sulphate 100mg/50mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Pharma-Ject Morphine sulphate 50mg/50mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Zomorph 200mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Zomorph 100mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Paramax sachet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Paramax tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Migravess Forte effervescent tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Migravess effervescent tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Migraleve yellow tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Migraleve pink tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Migraleve Duopack tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Morphine sulphate 100mg rectal tampon |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Sodium valproate 200mg e/c tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epilim Intravenous 400mg injection+diluent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epilim 200mg/5mL syrup |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epilim 200mg/5mL s/f liquid |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|